Extensive global pharmaceutical leadership experience in clinical development, operations, and medical affairsFocused psychiatry practice expert in PTSD, Affective Disorders and SchizophreniaProven track record in research as an investigator and academic grant-funded researcher Visiting Scholar at Stanford University, Center for Precision Mental Health and WellnessFormer roles at Boehringer Ingelheim and Pendulum Therapeutics RADNOR, Pa., Dec. 5, 2022 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage central nervous system (CNS) biopharmaceutical company, today announced the appointment of Carrie M. Carretta, PhD, APN-BC, AHN-BC,